Archive · 10 Sep 2026
Three Indian Specialty Chemical Smallcaps Ride A China+1 Shift
The article looks at three Indian chemical companies that may benefit as global customers seek alternatives to China.
Yasho Industries makes rubber chemicals, lubricant additives and aroma chemicals.
Privi Speciality Chemicals mainly makes chemicals used in fragrances and personal-care products.
Aether Industries makes specialty chemicals and is moving toward contract manufacturing.
All three companies reported stronger financial results in the periods discussed.
Aether and Privi already have relatively high profitability, while Yasho is recovering from earlier pricing pressure.
The companies are adding capacity and pursuing more specialized products and long-term customer relationships.
However, their share prices and valuations may already reflect high expectations.
Investors will need to see whether planned capacity and customer commitments produce lasting revenue and profits.
Yasho Industries reported Q1FY27 revenue growth of 55% and EBITDA margins of 24.2%, supported by volume recovery and improved pricing.
Privi Speciality Chemicals increased Q1FY27 revenue 19% and net profit 44%, while maintaining a 24.6% EBITDA margin.
Aether Industries grew Q1FY27 revenue 27.3% and net profit 33.4%, with CEM and CRAMS contributing about 60% of revenue.
Yasho plans ₹250 crore of FY27 capex, while Privi targets ₹5,000 crore revenue and more than ₹1,000 crore EBITDA within three to four years.
The article says valuations are demanding for Yasho and Aether, making execution, margins and customer commitments important investor watchpoints.
- Who
- Yasho Industries, Privi Speciality Chemicals and Aether Industries.
- What
- The companies are presented as three different ways to participate in India’s specialty-chemicals and China+1 opportunity.
- When
- The financial data covers FY25, FY26 and Q1FY27; the article also cites July 2026 and valuation data dated August 8, 2026.
- Where
- India, with the companies supplying domestic and international customers.
- Why
- Global customers are diversifying suppliers beyond China, while Indian manufacturers are moving toward specialized products, contract manufacturing and higher-value applications.
Growth Opportunity
Execution And Valuation Risks
China+1 demand
Growth Opportunity
Global customers are diversifying supply chains beyond China, potentially benefiting Indian companies with technical capabilities and customer approvals.
Execution And Valuation Risks
Export exposure alone may not be enough; companies must convert approvals, capacity additions and customer commitments into recurring revenue.
Business transformation
Growth Opportunity
Aether’s growing CEM and CRAMS mix, Privi’s expansion plans and Yasho’s new capacity could support higher-value growth and stronger margins.
Execution And Valuation Risks
The expected benefits depend on successful execution, sustained margins and demand matching the companies’ ambitious targets.
Stock valuations
Growth Opportunity
Strong earnings growth and structural industry opportunities may support premium valuations, particularly if the companies meet their plans.
Execution And Valuation Risks
Yasho and Aether trade at high reported trailing P/E multiples, so slower growth or weaker margins could lead to significant re-rating pressure.
- Yasho Q1FY27 revenue
- ₹308 crore, up 55% year over year
- Yasho Q1FY27 EBITDA margin
- 24.2%, compared with 16.5% in Q1FY26
- Privi Q1FY27 net profit
- ₹82.8 crore, up 43.75% year over year
- Aether Q1FY27 revenue
- ₹327 crore, up 27.3% year over year
- Aether contract-manufacturing contribution
- CEM and CRAMS contributed around 60% of revenue
- Yasho FY27 capex plan
- ₹250 crore, mainly for new production blocks at its Pakhajan facility
- Reported trailing P/E
- Yasho Industries: 94.0; Privi Industries: 38.8; Aether Industries: 90.9, based on August 8, 2026 data